{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:23:30Z","timestamp":1793125410133,"version":"4.5.0"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.lfs.2023.121947","type":"journal-article","created":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T01:30:20Z","timestamp":1689471020000},"page":"121947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"special_numbering":"C","title":["Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD)"],"prefix":"10.1016","volume":"329","author":[{"given":"Maryam","family":"Hemmati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setayesh","family":"Kashanipoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payman","family":"Mazaheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Alibabaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Babaeizad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shima","family":"Asli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hosein","family":"Gorgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Ghods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9889-2195","authenticated-orcid":false,"given":"Bahman","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5118-678X","authenticated-orcid":false,"given":"Majid","family":"Eslami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lfs.2023.121947_bb0005","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/1751-7915.13524","article-title":"The gut microbiota and its interactions with cardiovascular disease","volume":"13","author":"Xu","year":"2020","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.lfs.2023.121947_bb0010","first-page":"713","article-title":"The gut microbiota (microbiome) in cardiovascular disease and its therapeutic regulation","author":"Rahman","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121947_bb0015","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3892\/ijmm.2020.4674","article-title":"Gut microbiota metabolites as integral mediators in cardiovascular diseases","volume":"46","author":"Zhu","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2023.121947_bb0020","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/nu13020639","article-title":"Fat, sugar or gut microbiota in reducing cardiometabolic risk: does diet type really matter?","volume":"13","author":"Nabrdalik","year":"2021","journal-title":"Nutrients."},{"issue":"21","key":"10.1016\/j.lfs.2023.121947_bb0025","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1007\/s00018-018-2901-1","article-title":"Implication of gut microbiota metabolites in cardiovascular and metabolic diseases","volume":"75","author":"Brial","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"8","key":"10.1016\/j.lfs.2023.121947_bb0030","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.3390\/nu13082679","article-title":"Gut microbiota and subclinical cardiovascular disease in patients with type 2 diabetes mellitus","volume":"13","author":"Tsai","year":"2021","journal-title":"Nutrients."},{"key":"10.1016\/j.lfs.2023.121947_bb0035","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.3389\/fmicb.2017.01936","article-title":"Role of gut microbiota on cardio-metabolic parameters and immunity in coronary artery disease patients with and without type-2 diabetes mellitus","volume":"8","author":"Sanchez-Alcoholado","year":"2017","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121947_bb0040","first-page":"H923","article-title":"The gut microbiome and cardiovascular disease: current knowledge and clinical potential","volume":"317","author":"Ahmad","year":"2019","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"2","key":"10.1016\/j.lfs.2023.121947_bb0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.15420\/cfr.2018.39.2","article-title":"Diet, the gut microbiome and heart failure","volume":"5","author":"Harikrishnan","year":"2019","journal-title":"Card. Fail. Rev."},{"key":"10.1016\/j.lfs.2023.121947_bb0050","first-page":"462","article-title":"Intestinal microbiota and cardiovascular diseases","volume":"33","author":"Luz","year":"2020","journal-title":"Int. J. Cardiovasc. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2023.121947_bb0055","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.artere.2018.11.004","article-title":"Gut microbiota: a new protagonist in the risk of cardiovascular disease?","volume":"31","author":"Garc\u00eda-R\u00edos","year":"2019","journal-title":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis (English Edition)."},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-020-00821-0","article-title":"Gut microbiota and cardiovascular disease: opportunities and challenges","volume":"8","author":"Kazemian","year":"2020","journal-title":"Microbiome."},{"key":"10.1016\/j.lfs.2023.121947_bb0065","article-title":"Probiotics can really cure an autoimmune disease?","volume":"15","author":"Yousefi","year":"2019","journal-title":"Gene Rep."},{"issue":"7","key":"10.1016\/j.lfs.2023.121947_bb0070","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004947","article-title":"Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies","volume":"6","author":"Heianza","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.lfs.2023.121947_bb0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/07853890.2017.1417631","article-title":"The role of mitochondrial dysfunction in cardiovascular disease: a brief review","volume":"50","author":"Chistiakov","year":"2018","journal-title":"Ann. Med."},{"issue":"5","key":"10.1016\/j.lfs.2023.121947_bb0080","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.jvs.2017.09.029","article-title":"Plasma microbiome-modulated indole-and phenyl-derived metabolites associate with advanced atherosclerosis and postoperative outcomes","volume":"68","author":"Cason","year":"2018","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.lfs.2023.121947_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.648259","article-title":"Gut-derived metabolite Indole-3-propionic acid modulates mitochondrial function in cardiomyocytes and alters cardiac function","volume":"8","author":"Gesper","year":"2021","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/SPC.0000000000000414","article-title":"The role of splanchnic congestion and the intestinal microenvironment in the pathogenesis of advanced heart failure","volume":"13","author":"Polsinelli","year":"2019","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"10.1016\/j.lfs.2023.121947_bb0095","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5587428","article-title":"The correlation between gut microbiota and serum metabolomic in elderly patients with chronic heart failure","volume":"2021","author":"Wang","year":"2021","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0100","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1253\/circj.CJ-18-0468","article-title":"Gut microbiome and plasma microbiome-related metabolites in patients with decompensated and compensated heart failure","volume":"83","author":"Hayashi","year":"2018","journal-title":"Circ. J."},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0105","first-page":"1","article-title":"Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients","volume":"8","author":"Cui","year":"2018","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.lfs.2023.121947_bb0110","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/jth.14234","article-title":"Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk","volume":"16","author":"Zhu","year":"2018","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-00900-1","article-title":"The gut microbiome in atherosclerotic cardiovascular disease","volume":"8","author":"Jie","year":"2017","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.lfs.2023.121947_bb0120","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/CIRCRESAHA.116.309219","article-title":"Gut microbiome associates with lifetime cardiovascular disease risk profile among bogalusa heart study participants","volume":"119","author":"Kelly","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2023.121947_bb0125","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.micpath.2017.07.034","article-title":"The association of type II diabetes with gut microbiota composition","volume":"110","author":"Navab-Moghadam","year":"2017","journal-title":"Microb. Pathog."},{"issue":"7452","key":"10.1016\/j.lfs.2023.121947_bb0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature12198","article-title":"Gut metagenome in European women with normal, impaired and diabetic glucose control","volume":"498","author":"Karlsson","year":"2013","journal-title":"Nature."},{"key":"10.1016\/j.lfs.2023.121947_bb0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yjmcc.2020.12.001","article-title":"Gut microbiome-a potential mediator of pathogenesis in heart failure and its comorbidities: state-of-the-art review","volume":"152","author":"Mamic","year":"2021","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2023.121947_bb0140","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3796359","article-title":"Association study of gut flora in coronary heart disease through high-throughput sequencing","volume":"2017","author":"Cui","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2023.121947_bb0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bcp.2017.04.033","article-title":"The gut microbiota: a key factor in the therapeutic effects of (poly) phenols","volume":"139","author":"Esp\u00edn","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.lfs.2023.121947_bb0150","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1152\/physiolgenomics.00089.2016","article-title":"Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41","volume":"48","author":"Natarajan","year":"2016","journal-title":"Physiol. Genomics"},{"issue":"3","key":"10.1016\/j.lfs.2023.121947_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2021.101492","article-title":"Gut microbiota and their metabolites in cardiovascular disease","volume":"35","author":"Jansen","year":"2021","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0160","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/nu12010079","article-title":"The gut microbiota affects host pathophysiology as an endocrine organ: a focus on cardiovascular disease","volume":"12","author":"Busnelli","year":"2019","journal-title":"Nutrients."},{"issue":"5","key":"10.1016\/j.lfs.2023.121947_bb0165","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/apm.13038","article-title":"Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide","volume":"128","author":"Zhu","year":"2020","journal-title":"Apmis."},{"issue":"6","key":"10.1016\/j.lfs.2023.121947_bb0170","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/jnc.14928","article-title":"Enteric short-chain fatty acids promote proliferation of human neural progenitor cells","volume":"154","author":"Yang","year":"2020","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.lfs.2023.121947_bb0175","doi-asserted-by":"crossref","first-page":"17127","DOI":"10.1002\/jcp.28473","article-title":"Importance of probiotics in the prevention and treatment of colorectal cancer","volume":"234","author":"Eslami","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"10.1016\/j.lfs.2023.121947_bb0180","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3390\/nu9111236","article-title":"Dietary pea fiber supplementation improves glycemia and induces changes in the composition of gut microbiota, serum short chain fatty acid profile and expression of mucins in glucose intolerant rats","volume":"9","author":"Hashemi","year":"2017","journal-title":"Nutrients."},{"issue":"3","key":"10.1016\/j.lfs.2023.121947_bb0185","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ijo.2014.153","article-title":"The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents","volume":"39","author":"Psichas","year":"2015","journal-title":"Int. J. Obes."},{"issue":"11","key":"10.1016\/j.lfs.2023.121947_bb0190","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1073\/pnas.1215927110","article-title":"Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation","volume":"110","author":"Pluznick","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.lfs.2023.121947_bb0195","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4161\/gmic.27492","article-title":"A novel SCFA receptor, the microbiota, and blood pressure regulation","volume":"5","author":"Pluznick","year":"2014","journal-title":"Gut Microbes"},{"key":"10.1016\/j.lfs.2023.121947_bb0200","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.atherosclerosis.2020.08.028","article-title":"How strong is the evidence that gut microbiota composition can be influenced by lifestyle interventions in a cardio-protective way?","volume":"311 Oct","author":"Gerdes","year":"2020","journal-title":"Atherosclerosis."},{"issue":"3","key":"10.1016\/j.lfs.2023.121947_bb0205","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000522284","article-title":"The gut in heart failure: current knowledge and novel frontiers","volume":"31","author":"Gallo","year":"2022","journal-title":"Med. Princ. Pract."},{"issue":"2","key":"10.1016\/j.lfs.2023.121947_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264215","article-title":"Long-term high-fructose high-fat diet feeding elicits insulin resistance, exacerbates dyslipidemia and induces gut microbiota dysbiosis in WHHL rabbits","volume":"17","author":"Moughaizel","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2023.121947_bb0215","first-page":"9","article-title":"Role of the gut microbiota in glucose metabolism during heart failure","author":"Bao","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.lfs.2023.121947_bb0220","series-title":"Atherosclerosis Amelioration by Allicin in Raw Garlic through Gut Microbiota and Trimethylamine-N-Oxide Modulation","author":"Sheen","year":"2021"},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41522-021-00205-8","article-title":"Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome","volume":"7","author":"Li","year":"2021","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-021-02202-5","article-title":"Changes of gut microbiome composition and metabolites associated with hypertensive heart failure rats","volume":"21","author":"Li","year":"2021","journal-title":"BMC Microbiol."},{"issue":"9","key":"10.1016\/j.lfs.2023.121947_bb0235","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3390\/antiox9090856","article-title":"Maternal N-acetylcysteine therapy prevents hypertension in spontaneously hypertensive rat offspring: implications of hydrogen sulfide-generating pathway and gut microbiota","volume":"9","author":"Hsu","year":"2020","journal-title":"Antioxidants."},{"key":"10.1016\/j.lfs.2023.121947_bb0240","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2020.05.002","article-title":"Dietary sucrose induces metabolic inflammation and atherosclerotic cardiovascular diseases more than dietary fat in Ldlr\u2212\/\u2212 ApoB100\/100 mice","volume":"304","author":"Perazza","year":"2020","journal-title":"Atherosclerosis."},{"issue":"6","key":"10.1016\/j.lfs.2023.121947_bb0245","first-page":"H1210","article-title":"Gut microbiota regulates cardiac ischemic tolerance and aortic stiffness in obesity","volume":"317","author":"Battson","year":"2019","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"18","key":"10.1016\/j.lfs.2023.121947_bb0250","doi-asserted-by":"crossref","first-page":"1900073","DOI":"10.1002\/mnfr.201900073","article-title":"Targeting on gut microbial metabolite trimethylamine-N-oxide and short-chain fatty acid to prevent maternal high-fructose-diet-induced developmental programming of hypertension in adult male offspring","volume":"63","author":"Hsu","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.lfs.2023.121947_bb0255","first-page":"ess18221","article-title":"Effect of oat and tartary buckwheat\u2013based food on cholesterol\u2013lowering and gut microbiota in hypercholesterolemic hamsters","author":"Sun","year":"2019","journal-title":"J. Oleo Sci."},{"issue":"6","key":"10.1016\/j.lfs.2023.121947_bb0260","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3390\/nu10060761","article-title":"High-glucose or-fructose diet cause changes of the gut microbiota and metabolic disorders in mice without body weight change","volume":"10","author":"Do","year":"2018","journal-title":"Nutrients."},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-34970-y","article-title":"The prebiotic inulin modulates gut microbiota but does not ameliorate atherosclerosis in hypercholesterolemic APOE* 3-Leiden. CETP mice","volume":"8","author":"Hoving","year":"2018","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.lfs.2023.121947_bb0270","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3390\/nu10091154","article-title":"A high salt diet modulates the gut microbiota and short chain fatty acids production in a salt-sensitive hypertension rat model","volume":"10","author":"Bier","year":"2018","journal-title":"Nutrients."},{"issue":"8","key":"10.1016\/j.lfs.2023.121947_bb0275","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1039\/C8FO00349A","article-title":"Lactobacillus plantarum ZDY04 exhibits a strain-specific property of lowering TMAO via the modulation of gut microbiota in mice","volume":"9","author":"Qiu","year":"2018","journal-title":"Food Funct."},{"issue":"15","key":"10.1016\/j.lfs.2023.121947_bb0280","doi-asserted-by":"crossref","first-page":"1800066","DOI":"10.1002\/mnfr.201800066","article-title":"Resveratrol prevents the development of hypertension programmed by maternal plus post-weaning high-fructose consumption through modulation of oxidative stress, nutrient-sensing signals, and gut microbiota","volume":"62","author":"Tain","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"issue":"10","key":"10.1016\/j.lfs.2023.121947_bb0285","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/CIRCULATIONAHA.116.024545","article-title":"High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice","volume":"135","author":"Marques","year":"2017","journal-title":"Circulation."},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0290","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nm.4236","article-title":"A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice","volume":"23","author":"Plovier","year":"2017","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.lfs.2023.121947_bb0295","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/mnfr.201500738","article-title":"Lingonberries reduce atherosclerosis in Apoe-\/-mice in association with altered gut microbiota composition and improved lipid profile","volume":"60","author":"Matziouridou","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"issue":"2","key":"10.1016\/j.lfs.2023.121947_bb0300","doi-asserted-by":"crossref","first-page":"e02210","DOI":"10.1128\/mBio.02210-15","article-title":"Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota","volume":"7","author":"Chen","year":"2016","journal-title":"MBio."},{"key":"10.1016\/j.lfs.2023.121947_bb0305","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jff.2015.04.001","article-title":"Dietary allicin reduces transformation of L-carnitine to TMAO through impact on gut microbiota","volume":"15","author":"Wu","year":"2015","journal-title":"J. Funct. Foods"},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0310","doi-asserted-by":"crossref","DOI":"10.1186\/s12866-021-02202-5","article-title":"Changes of gut microbiome composition and metabolites associated with hypertensive heart failure rats","volume":"21","author":"Li","year":"2021","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.lfs.2023.121947_bb0315","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/bs.acc.2019.07.002","article-title":"Cytokines in heart failure","volume":"93","author":"Stanciu","year":"2019","journal-title":"Adv. Clin. Chem."},{"issue":"7","key":"10.1016\/j.lfs.2023.121947_bb0320","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1073\/pnas.1317834111","article-title":"Trimethylamine N-oxide metabolism by abundant marine heterotrophic bacteria","volume":"111","author":"Lidbury","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.lfs.2023.121947_bb0325","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.lfs.2023.121947_bb0330","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/j.jrn.2015.02.006","article-title":"Associations of trimethylamine N-oxide with nutritional and inflammatory biomarkers and cardiovascular outcomes in patients new to dialysis","volume":"25","author":"Kaysen","year":"2015","journal-title":"J. Ren. Nutr."},{"issue":"3","key":"10.1016\/j.lfs.2023.121947_bb0335","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.lfs.2023.121947_bb0340","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmet.2014.10.006","article-title":"\u03b3-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO","volume":"20","author":"Koeth","year":"2014","journal-title":"Cell Metab."},{"issue":"17","key":"10.1016\/j.lfs.2023.121947_bb0345","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.lfs.2023.121947_bb0350","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1073\/pnas.1316569111","article-title":"Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota","volume":"111","author":"Zhu","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2023.121947_bb0355","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02481-14","article-title":"Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide","volume":"6","author":"Romano","year":"2015","journal-title":"MBio."},{"issue":"6","key":"10.1016\/j.lfs.2023.121947_bb0360","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1161\/ATVBAHA.114.303252","article-title":"Comparative genome-wide association studies in mice and humans for trimethylamine N-oxide, a proatherogenic metabolite of choline and L-carnitine","volume":"34","author":"Hartiala","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.lfs.2023.121947_bb0365","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1210\/clinem\/dgac210","article-title":"Cardiovascular benefits of empagliflozin are associated with gut microbiota and plasma metabolites in type 2 diabetes","volume":"107","author":"Deng","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"13","key":"10.1016\/j.lfs.2023.121947_bb0370","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020654","article-title":"The gut microbiome of heart failure with preserved ejection fraction","volume":"10","author":"Beale","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"15","key":"10.1016\/j.lfs.2023.121947_bb0375","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016641","article-title":"Association between the gut microbiota and blood pressure in a population cohort of 6953 individuals","volume":"9","author":"Palmu","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"11","key":"10.1016\/j.lfs.2023.121947_bb0380","doi-asserted-by":"crossref","first-page":"14166","DOI":"10.1096\/fj.202000622R","article-title":"Metagenomic analysis of the gut microbiome in atherosclerosis patients identify cross-cohort microbial signatures and potential therapeutic target","volume":"34","author":"Liu","year":"2020","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.lfs.2023.121947_bb0385","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/HYPERTENSIONAHA.118.12109","article-title":"Gut microbiota composition and blood pressure: the CARDIA study","volume":"73","author":"Sun","year":"2019","journal-title":"Hypertension."},{"issue":"6","key":"10.1016\/j.lfs.2023.121947_bb0390","doi-asserted-by":"crossref","first-page":"872","DOI":"10.7150\/ijms.29322","article-title":"Differential analysis of hypertension-associated intestinal microbiota","volume":"16","author":"Dan","year":"2019","journal-title":"Int. J. Med. Sci."},{"issue":"10","key":"10.1016\/j.lfs.2023.121947_bb0395","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jacc.2017.12.057","article-title":"Gut microbiota signature in heart failure defined from profiling of 2 independent cohorts","volume":"71","author":"Kummen","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2023.121947_bb0400","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fnut.2018.00122","article-title":"The effect of Kyolic aged garlic extract on gut microbiota, inflammation, and cardiovascular markers in hypertensives: the GarGIC trial","volume":"5","author":"Ried","year":"2018","journal-title":"Front. Nutr."},{"issue":"10","key":"10.1016\/j.lfs.2023.121947_bb0405","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1152\/physiolgenomics.00070.2018","article-title":"Dysbiosis signatures of gut microbiota in coronary artery disease","volume":"50","author":"Zhu","year":"2018","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.lfs.2023.121947_bb0410","article-title":"Non-ischemic heart failure with reduced ejection fraction is associated with altered intestinal microbiota","volume":"CJ-17-1285","author":"Katsimichas","year":"2018","journal-title":"Circ. J."},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-016-0222-x","article-title":"Gut microbiota dysbiosis contributes to the development of hypertension","volume":"5","author":"Li","year":"2017","journal-title":"Microbiome."},{"issue":"3","key":"10.1016\/j.lfs.2023.121947_bb0420","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ehf2.12155","article-title":"Heart failure is associated with depletion of core intestinal microbiota","volume":"4","author":"Luedde","year":"2017","journal-title":"ESC Heart Fail."},{"issue":"3","key":"10.1016\/j.lfs.2023.121947_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174099","article-title":"Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure","volume":"12","author":"Kamo","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.lfs.2023.121947_bb0430","first-page":"220","article-title":"Pathogenic gut flora in patients with chronic heart failure","volume":"4","author":"Pasini","year":"2016","journal-title":"JACC: Heart Fail."},{"key":"10.1016\/j.lfs.2023.121947_bb0435","article-title":"Analysis of gut microbiota in coronary artery disease patients: a possible link between gut microbiota and coronary artery disease","volume":"32672","author":"Emoto","year":"2016","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.lfs.2023.121947_bb0440","first-page":"129","article-title":"High molecular weight barley \u03b2-glucan alters gut microbiota toward reduced cardiovascular disease risk","volume":"7","author":"Wang","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.lfs.2023.121947_bb0445","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1578320","article-title":"The association between plasma levels of trimethylamine N-oxide and the risk of coronary heart disease in Chinese patients with or without type 2 diabetes mellitus","volume":"2018","author":"Dong","year":"2018","journal-title":"Dis. Markers"},{"issue":"8","key":"10.1016\/j.lfs.2023.121947_bb0450","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3390\/nu11081821","article-title":"The microbial metabolite trimethylamine N-oxide links vascular dysfunctions and the autoimmune disease rheumatoid arthritis","volume":"11","author":"Chan","year":"2019","journal-title":"Nutrients."},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0455","doi-asserted-by":"crossref","first-page":"1600324","DOI":"10.1002\/mnfr.201600324","article-title":"Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: a randomized controlled trial","volume":"61","author":"Cho","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"issue":"2","key":"10.1016\/j.lfs.2023.121947_bb0460","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41591-020-01223-3","article-title":"The gut microbiome modulates the protective association between a Mediterranean diet and cardiometabolic disease risk","volume":"27","author":"Wang","year":"2021","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0465","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/1462-2920.13463","article-title":"Pediatric obesity is associated with an altered gut microbiota and discordant shifts in F irmicutes populations","volume":"19","author":"Riva","year":"2017","journal-title":"Environ. Microbiol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121947_bb0470","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/metabo11080493","article-title":"Exploring the gut microbiota and cardiovascular disease","volume":"11","author":"Murphy","year":"2021","journal-title":"Metabolites."},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0475","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41367-020-0017-1","article-title":"From obesity through gut microbiota to cardiovascular diseases: a dangerous journey","volume":"10","author":"Marzullo","year":"2020","journal-title":"Int. J. Obes. Suppl."},{"key":"10.1016\/j.lfs.2023.121947_bb0480","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4634172","article-title":"Trimethylamine N-oxide generated by the gut microbiota is associated with vascular inflammation: new insights into atherosclerosis","volume":"2020","author":"Liu","year":"2020","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.lfs.2023.121947_bb0485","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MOL.0000000000000278","article-title":"Expanding role of gut microbiota in lipid metabolism","volume":"27","author":"Ghazalpour","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"issue":"9","key":"10.1016\/j.lfs.2023.121947_bb0490","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/jcm6090086","article-title":"Gut microbiota-dependent trimethylamine-N-oxide and serum biomarkers in patients with T2DM and advanced CKD","volume":"6","author":"Al-Obaide","year":"2017","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.lfs.2023.121947_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26041172","article-title":"Role of gut microbiota, probiotics and prebiotics in the cardiovascular diseases","volume":"26","author":"Oniszczuk","year":"2021","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0500","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cmet.2012.12.011","article-title":"Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation","volume":"17","author":"Bennett","year":"2013","journal-title":"Cell Metab."},{"issue":"22","key":"10.1016\/j.lfs.2023.121947_bb0505","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2023.121947_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.100976","article-title":"Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment","volume":"36","author":"Kappel","year":"2020","journal-title":"Mol. Metab."},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-018-0433-4","article-title":"High salt diet exacerbates colitis in mice by decreasing Lactobacillus levels and butyrate production","volume":"6","author":"Miranda","year":"2018","journal-title":"Microbiome."},{"issue":"6416","key":"10.1016\/j.lfs.2023.121947_bb0520","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1126\/science.aau5812","article-title":"The gut microbiota at the intersection of diet and human health","volume":"362","author":"Gentile","year":"2018","journal-title":"Science."},{"key":"10.1016\/j.lfs.2023.121947_bb0525","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.nut.2018.11.015","article-title":"Trimethylamine N-oxide, Mediterranean diet, and nutrition in healthy, normal-weight adults: also a matter of sex?","volume":"62","author":"Barrea","year":"2019","journal-title":"Nutrition."},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-33893-y","article-title":"Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice","volume":"8","author":"Lai","year":"2018","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.lfs.2023.121947_bb0535","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/CIRCULATIONAHA.118.036652","article-title":"Short-chain fatty acid propionate protects from hypertensive cardiovascular damage","volume":"139","author":"Bartolomaeus","year":"2019","journal-title":"Circulation."},{"issue":"17","key":"10.1016\/j.lfs.2023.121947_bb0540","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCULATIONAHA.116.025338","article-title":"Gut microbe-generated trimethylamine N-oxide from dietary choline is prothrombotic in subjects","volume":"135","author":"Zhu","year":"2017","journal-title":"Circulation."},{"issue":"4","key":"10.1016\/j.lfs.2023.121947_bb0545","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.celrep.2018.06.096","article-title":"A multi-omic association study of trimethylamine N-oxide","volume":"24","author":"Manor","year":"2018","journal-title":"Cell Rep."},{"issue":"7341","key":"10.1016\/j.lfs.2023.121947_bb0550","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature."},{"issue":"7","key":"10.1016\/j.lfs.2023.121947_bb0555","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","article-title":"Gut microbiota in cardiovascular health and disease","volume":"120","author":"Tang","year":"2017","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.lfs.2023.121947_bb0560","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s10482-020-01474-7","article-title":"Human gut microbiota\/microbiome in health and diseases: a review","volume":"113","author":"Gomaa","year":"2020","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"7","key":"10.1016\/j.lfs.2023.121947_bb0565","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nm.4345","article-title":"Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug","volume":"23","author":"Wu","year":"2017","journal-title":"Nat. Med."},{"issue":"Supplement_1","key":"10.1016\/j.lfs.2023.121947_bb0570","article-title":"10. Cardiovascular disease and risk management: standards of medical care in diabetes\u20142020","volume":"43","author":"Association AD","year":"2020","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.lfs.2023.121947_bb0575","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41564-018-0272-x","article-title":"Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model","volume":"3","author":"Kasahara","year":"2018","journal-title":"Nat. Microbiol."},{"issue":"3","key":"10.1016\/j.lfs.2023.121947_bb0580","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/1753-0407.12986","article-title":"Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression","volume":"12","author":"Xu","year":"2020","journal-title":"J. Diabetes."},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0585","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.chembiol.2018.10.003","article-title":"Bile acid 7\u03b1-dehydroxylating gut bacteria secrete antibiotics that inhibit Clostridium difficile: role of secondary bile acids","volume":"26","author":"Kang","year":"2019","journal-title":"Cell Chem. Biol."},{"issue":"6","key":"10.1016\/j.lfs.2023.121947_bb0590","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00094-18","article-title":"Butyrate producers as potential next-generation probiotics: safety assessment of the administration of Butyricicoccus pullicaecorum to healthy volunteers","volume":"3","author":"Boesmans","year":"2018","journal-title":"Msystems."},{"key":"10.1016\/j.lfs.2023.121947_bb0595","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3389\/fmicb.2019.01947","article-title":"Alterations in gut microbiota by statin therapy and possible intermediate effects on hyperglycemia and hyperlipidemia","volume":"10","author":"Kim","year":"2019","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.lfs.2023.121947_bb0600","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/CIRCULATIONAHA.118.035235","article-title":"Loss of gut microbiota alters immune system composition and cripples postinfarction cardiac repair","volume":"139","author":"Tang","year":"2019","journal-title":"Circulation."},{"issue":"17","key":"10.1016\/j.lfs.2023.121947_bb0605","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1042\/CS20190171","article-title":"Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease","volume":"133","author":"Wang","year":"2019","journal-title":"Clin. Sci."},{"key":"10.1016\/j.lfs.2023.121947_bb0610","first-page":"701","article-title":"Special issue \u201coxidative stress in aging and associated chronic diseases\u201d","author":"Mas-Bargues","year":"2022","journal-title":"MDPI"},{"issue":"1","key":"10.1016\/j.lfs.2023.121947_bb0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-14177-z","article-title":"Impact of commonly used drugs on the composition and metabolic function of the gut microbiota","volume":"11","author":"Vich Vila","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2023.121947_bb0620","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.lfs.2018.10.063","article-title":"Interaction between gut microbiome and cardiovascular disease","volume":"214","author":"Peng","year":"2018","journal-title":"Life Sci."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523005829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523005829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T14:41:46Z","timestamp":1736347306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523005829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":124,"alternative-id":["S0024320523005829"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121947","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD)","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121947"}}